Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $2.3 million.

  • Cryo Cell International's Accumulated Expenses fell 1477.29% to $2.3 million in Q3 2025 from the same period last year, while for Aug 2025 it was $2.3 million, marking a year-over-year decrease of 1477.29%. This contributed to the annual value of $5.8 million for FY2024, which is 1235.91% up from last year.
  • Per Cryo Cell International's latest filing, its Accumulated Expenses stood at $2.3 million for Q3 2025, which was down 1477.29% from $2.7 million recorded in Q2 2025.
  • Cryo Cell International's 5-year Accumulated Expenses high stood at $5.8 million for Q4 2024, and its period low was $1.5 million during Q2 2021.
  • In the last 5 years, Cryo Cell International's Accumulated Expenses had a median value of $2.7 million in 2024 and averaged $3.0 million.
  • Per our database at Business Quant, Cryo Cell International's Accumulated Expenses soared by 49008.1% in 2021 and then tumbled by 3914.46% in 2022.
  • Over the past 5 years, Cryo Cell International's Accumulated Expenses (Quarter) stood at $3.1 million in 2021, then grew by 17.28% to $3.6 million in 2022, then skyrocketed by 44.2% to $5.2 million in 2023, then rose by 12.36% to $5.8 million in 2024, then plummeted by 60.68% to $2.3 million in 2025.
  • Its Accumulated Expenses was $2.3 million in Q3 2025, compared to $2.7 million in Q2 2025 and $4.3 million in Q1 2025.